Michael Uchrin, M.B.A. M.Eng
CEO and Co-Founder
Mike Uchrin is an accomplished senior executive, recently having led the growth of Health Choice, the managed care and insurance business unit of private equity sponsored Iasis Healthcare (recently acquired by Steward Health Care) from a small Arizona Medicaid plan into a robust regional managed care organization operating five health plans and two accountable care networks. Under Mike’s leadership, Health Choice grew to more than 650,000 distinct Medicaid, Medicare, and commercial members through its health plans, integrated delivery networks, and managed care solutions for self-insured employers. More specifically, Mike focused significantly on the development of physician-led clinically integrated networks whose primary care, specialists, and hospital affiliates lowered costs and improved quality outcomes for Medicaid, Medicare, commercial, and self-insured individuals through a comprehensive MSO platform that included extensive care management, quality, and member engagement services. Prior to becoming the President and Chief Executive Officer of Health Choice in 2012, Mike served as the Chief Operating Officer beginning in 2006, and as the Chief Information Officer in 2005. Mike received his Bachelor of Science in GeoPhysics from The University of Arizona as well as a Master of Business Administration and a Master of Engineering in Software from Arizona State University.
Senator William H. Frist, M.D.
Senator Frist is a leading authority on healthcare and former U.S. Senate Majority Leader. He is a co-founder and partner at Frist Cressey Ventures. Dr. Frist resides on the fund's Investment Committee and is responsible for acquisition, divestitures and providing unique value to the fund's partnerships. Senator Frist served two terms as a United States Senator representing Tennessee as Majority Leader from 2003 until his retirement in 2007. His leadership was instrumental in the passage of the 2003 Medicare Modernization Act and the historic PEPFAR legislation that provided life-saving treatment globally to over 12 million people. Prior to the Senate, Dr. Frist founded the Vanderbilt Multi-Organ Transplant Center and has performed more than 150 heart and lung transplant procedures. His current board service includes Select Medical (NYSE: SEM), AECOM (NYSE: ACM), Teladoc (NYSE: TDOC), Aspire Health, Aegis Sciences, Accolade, Kaiser Family Foundation, Robert Wood Johnson Foundation, The Nature Conservancy, Smithsonian National Museum of the American Indian, Bipartisan Policy Center, and Nashville Health Care Council. Senator Frist received his M.D. from Harvard Medical School and holds a B.A. from Princeton University.
Raymond Hakim, M.D. Ph.D.
Chief Medical Officer and
Clinical Advisory Committee Chair
Dr. Raymond Hakim is a nationally recognized Nephrologist who is also currently a clinical Professor of Medicine in the Division of Nephrology at Vanderbilt University. Dr. Hakim was the Chief Medical Officer and Senior Executive Vice President, Clinical and Scientific Affairs for Fresenius Medical Services until December 2011. He started his career as an engineer graduating from MIT and worked as a research engineer until he was accepted into medical school. He has been a faculty member of Harvard and Brigham and Women’s Hospital in Boston before joining the faculty at Vanderbilt in 1987 where he was the Director of the Clinical Division of Nephrology as well as Medical Director of Vanderbilt Dialysis. He has done internationally recognized research in the areas of dialysis and the care of dialysis patients. In 1995, Dr. Hakim became one of the founders of Renal Care group which in 2005 had the lowest mortality and morbidity rate among other dialysis providers as published by the USRDS. He attributes this success to a team effort in applying the principles of Continuous Quality Improvement throughout the organization. Through Dr. Hakim’s 190 publications as well as many past and current presentations, he educates many faculty as well as Nephrologists practicing nationally regarding the treatment of kidney disease. Dr. Hakim received many national and international awards in recognition of his dedication to improving the outcomes of patients with CKD and ESRD.
Christopher A. Booker
Co-Founder and Director
Christopher Booker is a successful venture capital investor and joined Frist Cressey Ventures as a partner in 2016. Mr. Booker leads the firm's investment team, serves on the fund's Investment Committee, and is responsible for acquisition, expenditures, and providing unique value to the fund's partnerships. Mr. Booker has been an investor and/or served on the board of several leading enterprises including: ProiverTrust, NContracts, Criterion Holdings Corporation, Woodland Street Partners, Stratasan, Paragon Group, and FCV's partnerships. In addition to his responsibilities at FCV, he is an active board member to nonprofit organizations in the Nashville area. Prior to joining FCV, Mr. Booker was a partner at XMi Holdings, Inc. managing their investment funds and President of XMi Capital where he participated in over 50 transactions. While at XMi Holdings, he was CFO and served as a director to healthcare services firm Criterion Holdings Corporation, Inc. Criterion grew from 3 employees to nearly 600 before being acquired in 2016. Mr. Booker is a graduate of Vanderbilt University with a B.S. in Engineering and Economics.
Chief Operating Officer
Chris Chi is a healthcare executive with leadership experience at managed care organizations, a national hospital system, and a publicly-traded behavioral healthcare care provider. In these roles, he has helped develop and implement quality improvement and shared savings programs in collaboration with health insurance plans, physician groups and other healthcare providers. Mr. Chi was previously an M&A and securities law partner in private practice. In that role, he advised on M&A transactions involving hospital systems, physician practices and healthcare information technology companies. In general counsel roles at two leading healthcare companies, he led initiatives involving health plan formation and operations, network development and governmental program compliance. Chris received his bachelor's degree from Harvard University and is a graduate of the University of Virginia School of Law.
Shaminder M. Gupta, M.D.
Corporate Medical Director
Dr. Shaminder Gupta is a nationally recognized nephrologist and physician executive with over 15 years of experience. He completed his residency at the Louisiana State Univeristy Health Sciences Center in New Orleans and is well recognized for his growth of home modalities in rural Louisiana where over 40% of his patients dialyze at home. To further the adoption of home modalities, Dr. Gupta created the Louisiana home dialysis task force and served on the board of the foundation. In his role as Corporate Medical Director at Monogram, Dr. Gupta oversees the development and implementation of clinical strategies, expanding the network of partner nephrologists, encouraging a conservative care approach where appropriate and optimizing patient outcomes through adherence to evidence-based clinical care guidelines. Dr. Gupta is the immediate past president of the National Kidney Foundation of Louisiana and has a faculty appointment at Tulane University Health Sciences Center where he has won numerous teaching awards at his home institution.
Deborah Robin, M.D.
SVP, Clincal Performance
Dr. Deborah W. Robin is an experienced Geriatrician and physician executive with clinical and administrative medicine accomplishments in acute and post-acute care as well as in corporate settings. Dr. Robin completed her Internal Medicine Residency and Fellowship in Rheumatology at Case Western Reserve/University Hospitals of Cleveland as well as a Fellowship in Geriatric Medicine at the University of Washington. Dr Robin excelled in academic medicine at Vanderbilt University where she conducted Clinical Pharmacology research as well as assisted in the launch and clinical excellence of recognized Vanderbilt Medical Center Services including the Subacute Care Unit, Elderly Inpatient Unit, as well as affiliated nursing homes. Since 2011, Dr. Robin has focused on leading clinical operations for notable managed care technology and services firms including Lumeris, naviHealth, and now Monogram Health. In these roles she has driven industry leading outcomes in very highly complex cohorts of patients through the development and implementation of evidence based criteria and sophisticated clinical care pathways.
VP, Enterprise Programs
Katrina Cope is a results-driven healthcare executive with expertise leading effective business strategy, operations performance, and cross-functional leadership within complex healthcare organizations supporting large scale multi-million dollar projects. Katrina also has expertise in leading teams of cross-functional professionals in the implementation of health plan and managed care operational strategies that improve financial results, raise quality, drive consumer engagement, and increase employee engagement. As an effective communicator, Mrs. Cope also leverages a commitment to excellence to launch, build, and lead deployment of innovative products and services. Katrina holds a Master of Science in Leadership from Grand Canyon University.